MRK
NYSEMerck & Co., Inc.
Health Care, Pharmaceuticals
$128.58
close 7 Aug 2026
+60.66%
52-week change
$317.57B
market cap
$77.58
$135.05
52-week range
| Line item | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income | ||||||||||||||||||||
| Revenue | $66.57B | $65.01B | $64.17B | $60.12B | $59.28B | $48.70B | $41.52B | $39.12B | $42.29B | $40.12B | $39.81B | $39.50B | $42.24B | $44.03B | $47.27B | $48.05B | $45.99B | $27.43B | $23.85B | $24.20B |
| Cost of revenue | $18.00B | $16.38B | $15.19B | $16.13B | $17.41B | $13.63B | $13.62B | $12.02B | $13.51B | $12.91B | $14.03B | $14.93B | $16.77B | $16.95B | $16.45B | $16.87B | $18.40B | $9.02B | $5.58B | $6.14B |
| Gross profit | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| R&D | $30.45B | $15.79B | $17.94B | $30.53B | $13.55B | $12.25B | $13.40B | $9.72B | $9.75B | $10.34B | $10.26B | $6.70B | $7.18B | $7.50B | $8.17B | $8.47B | $11.11B | $5.85B | $4.81B | $4.88B |
| SG&A | $11.14B | $10.73B | $10.82B | $10.50B | $10.04B | $9.63B | $8.96B | $9.46B | $10.10B | $10.07B | $10.02B | $10.31B | $11.61B | $11.91B | $12.78B | $13.73B | $13.13B | $8.54B | $7.38B | $7.56B |
| Operating income | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Interest expense | $1.74B | $1.36B | $1.27B | $1.15B | $962.00M | $806.00M | $831.00M | $893.00M | $772.00M | $754.00M | $693.00M | $672.00M | $732.00M | $801.00M | $714.00M | $695.00M | $715.00M | $460.00M | $251.00M | — |
| Tax expense | $2.78B | $2.80B | $2.80B | $1.51B | $1.92B | $1.52B | $1.34B | $1.57B | $2.51B | $4.10B | $718.00M | $942.00M | $5.35B | $1.03B | $2.44B | $942.00M | $671.00M | $2.27B | $2.00B | $95.30M |
| Net income | $3.17B | $18.25B | $17.12B | $365.00M | $14.52B | $13.05B | $7.07B | $9.84B | $6.22B | $2.39B | $3.92B | $4.44B | $11.92B | $4.40B | $6.17B | $6.27B | $861.00M | $12.90B | $7.81B | $3.28B |
| Diluted EPS | $1.25 | $7.28 | $6.74 | $0.1400 | $5.71 | $5.14 | $2.78 | $3.81 | $2.32 | $0.8700 | $1.41 | $1.56 | $4.07 | $1.47 | $2.00 | $2.02 | $0.2800 | $5.65 | $3.63 | $1.49 |
| Gross margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net margin | 4.77% | 28.08% | 26.68% | 0.61% | 24.49% | 26.79% | 17.02% | 25.16% | 14.71% | 5.97% | 9.85% | 11.25% | 28.22% | 10.00% | 13.05% | 13.05% | 1.87% | 47.03% | 32.74% | 13.54% |
filed 7 Aug 2026